
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013

Intrinsic Value
The intrinsic value of one
Dr Sulaiman Al-Habib Medical Services Group Co
stock under the Base Case scenario is
196.11
SAR.
Compared to the current market price of 280 SAR,
Dr Sulaiman Al-Habib Medical Services Group Co
is
Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Dr Sulaiman Al-Habib Medical Services Group Co
Fundamental Analysis



Revenue & Expenses Breakdown
Dr Sulaiman Al-Habib Medical Services Group Co
Balance Sheet Decomposition
Dr Sulaiman Al-Habib Medical Services Group Co
Current Assets | 5.3B |
Cash & Short-Term Investments | 2.9B |
Receivables | 1.1B |
Other Current Assets | 1.3B |
Non-Current Assets | 15.2B |
Long-Term Investments | 465.4m |
PP&E | 14.8B |
Free Cash Flow Analysis
Dr Sulaiman Al-Habib Medical Services Group Co
SAR | |
Free Cash Flow | SAR |
Earnings Waterfall
Dr Sulaiman Al-Habib Medical Services Group Co
Revenue
|
11.2B
SAR
|
Cost of Revenue
|
-7.5B
SAR
|
Gross Profit
|
3.7B
SAR
|
Operating Expenses
|
-1.4B
SAR
|
Operating Income
|
2.4B
SAR
|
Other Expenses
|
-41m
SAR
|
Net Income
|
2.3B
SAR
|
Profitability Score
Profitability Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Score
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Score
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dr Sulaiman Al-Habib Medical Services Group Co
According to Wall Street analysts, the average 1-year price target for
Dr Sulaiman Al-Habib Medical Services Group Co
is 308.26 SAR
with a low forecast of 247.45 SAR and a high forecast of 346.5 SAR.
Dividends
Current shareholder yield for Dr Sulaiman Al-Habib Medical Services Group Co is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Dr Sulaiman Al-Habib Medical Services Group Co
stock under the Base Case scenario is
196.11
SAR.
Compared to the current market price of 280 SAR,
Dr Sulaiman Al-Habib Medical Services Group Co
is
Overvalued by 30%.